Psychemedics (PMD)
(Delayed Data from NSDQ)
$2.33 USD
0.00 (0.00%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $2.33 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Psychemedics Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 2 | 5 | 2 | 3 | 7 |
Receivables | 4 | 4 | 7 | 6 | 4 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 1 | 1 | 2 | 1 | 2 |
Total Current Assets | 7 | 10 | 10 | 10 | 13 |
Net Property & Equipment | 3 | 5 | 7 | 9 | 11 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 1 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 12 | 19 | 22 | 24 | 28 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 0 | 1 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 1 | 1 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 4 | 3 | 2 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 5 | 6 | 6 | 4 | 6 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 1 | 3 | 2 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 6 | 8 | 9 | 11 | 11 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 35 | 34 | 33 | 33 | 32 |
Retained Earnings | -17 | -12 | -10 | -9 | -4 |
Other Equity | -2 | -2 | -2 | -2 | -2 |
Treasury Stock | 10 | 10 | 10 | 10 | 10 |
Total Shareholder's Equity | 7 | 11 | 12 | 13 | 17 |
Total Liabilities & Shareholder's Equity | 12 | 19 | 22 | 24 | 28 |
Total Common Equity | 7 | 11 | 12 | 13 | 17 |
Shares Outstanding | 5.80 | 5.60 | 5.50 | 5.50 | 5.50 |
Book Value Per Share | 1.15 | 1.92 | 2.23 | 2.27 | 3.06 |
Fiscal Year End for Psychemedics Corporation falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1 | 1 | 2 | 1 | 2 |
Receivables | 3 | 4 | 4 | 5 | 4 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 2 | 1 | 1 | 2 | 2 |
Total Current Assets | 6 | 6 | 7 | 8 | 8 |
Net Property & Equipment | 3 | 3 | 3 | 3 | 4 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 1 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 10 | 11 | 12 | 14 | 16 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 1 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 1 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 2 | 2 | 3 | 3 | 3 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 4 | 4 | 5 | 5 | 6 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 4 | 5 | 6 | 7 | 7 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 36 | 35 | 35 | 35 | 35 |
Retained Earnings | -18 | -17 | -17 | -16 | -14 |
Other Equity | -2 | -2 | -2 | -2 | -2 |
Treasury Stock | 10 | 10 | 10 | 10 | 10 |
Total Shareholder's Equity | 6 | 6 | 7 | 7 | 9 |
Total Liabilities & Shareholder's Equity | 10 | 11 | 12 | 14 | 16 |
Total Common Equity | 6 | 6 | 7 | 7 | 9 |
Shares Outstanding | 5.80 | 5.80 | 5.80 | 5.70 | 5.70 |
Book Value Per Share | 0.99 | 1.08 | 1.15 | 1.30 | 1.60 |